ImmunologybioRxivPreprint
Targeting the Oxysterol Receptor GPR183 to Mitigate Fibrogenesis in Idiopathic Pulmonary Fibrosis
Minh Dao Ngo, Cheng Xiang Foo, Ziying Hong…·Katharina Ronacher
Targeting GPR183 reduced lung fibrosis and inflammation in a preclinical model, supporting GPR183 as a promising new therapy.
DOI 10.64898/2026.08.09.743811